227 related articles for article (PubMed ID: 23377970)
1. MicroRNAs in melanoma biology.
Kunz M
Adv Exp Med Biol; 2013; 774():103-20. PubMed ID: 23377970
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.
Mirzaei H; Gholamin S; Shahidsales S; Sahebkar A; Jaafari MR; Mirzaei HR; Hassanian SM; Avan A
Eur J Cancer; 2016 Jan; 53():25-32. PubMed ID: 26693896
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
[TBL] [Abstract][Full Text] [Related]
4. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
[TBL] [Abstract][Full Text] [Related]
6. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
7. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.
Mueller DW; Rehli M; Bosserhoff AK
J Invest Dermatol; 2009 Jul; 129(7):1740-51. PubMed ID: 19212343
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
Xu Y; Brenn T; Brown ER; Doherty V; Melton DW
Br J Cancer; 2012 Jan; 106(3):553-61. PubMed ID: 22223089
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
Mishra RR; Kneitz S; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
[TBL] [Abstract][Full Text] [Related]
11. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
Leibowitz-Amit R; Sidi Y; Avni D
Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
[TBL] [Abstract][Full Text] [Related]
12. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-dependent regulation of cKit in cutaneous melanoma.
Igoucheva O; Alexeev V
Biochem Biophys Res Commun; 2009 Feb; 379(3):790-4. PubMed ID: 19126397
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA regulation of melanoma progression.
Bonazzi VF; Stark MS; Hayward NK
Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
[TBL] [Abstract][Full Text] [Related]
16. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
20. New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.
Margue C; Philippidou D; Reinsbach SE; Schmitt M; Behrmann I; Kreis S
PLoS One; 2013; 8(9):e73473. PubMed ID: 24039954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
